SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework-Reference-Cited by-同舟云学术

SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework

Published:2018-03-23 Issue:7 Volume:59 Page:1085-1091
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Werner Rudolf A.,Solnes Lilja B.,Javadi Mehrbod S.,Weich Alexander,Gorin Michael A.,Pienta Kenneth J.,Higuchi Takahiro,Buck Andreas K.,Pomper Martin G.,Rowe Steven P.,Lapa Constantin

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference37 articles.

1. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

2. [177Lu-DOTA](0)-D-Phe(1)-Tyr(3)-Octreotide (177Lu-DOTATOC) for peptide receptor radiotherapy in patients with advanced neuroendocrine tumours: a phase-II study;Baum;Theranostics.,2016

3. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

4. Nicolas GP Beykan S Bouterfa H . Safety, biodistribution, and radiation dosimetry of 68Ga-OPS202 (68Ga-NODAGA-JR11) in patients with gastroenteropancreatic neuroendocrine tumors: a prospective phase I imaging study. J Nucl Med. October 12, 2017 [Epub ahead of print].

5. Nicolas GP Schreiter N Kaul F . Comparison of 68Ga-OPS202 (68Ga-NODAGA-JR11) and 68Ga-DOTATOC (68Ga-Edotreotide) PET/CT in patients with gastroenteropancreatic neuroendocrine tumors: evaluation of sensitivity in a prospective phase II imaging study. J Nucl Med. November 30, 2017 [Epub ahead of print].

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone Lymphoma;Molecular Imaging and Biology;2024-08-01

2. Outcome prediction of SSTR-RADS-3A and SSTR-RADS-3B lesions in patients with neuroendocrine tumors based on 68Ga-DOTATATE PET/MR;Journal of Cancer Research and Clinical Oncology;2024-05-25

3. Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [18F]SiTATE;European Radiology;2024-05-20

4. State-of-the-Art Hybrid Imaging of Neuroendocrine Neoplasms;Journal of Computer Assisted Tomography;2024-04-11

5. Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs);Theranostics;2024